BPC-157 + TB-500: side effects and evidence limits
The BPC-157 + TB-500 listing specifies BPC-157 10 mg and TB-500 10 mg as a lyophilized powder, naming TB-500 a thymosin β4 fragment. The fields read do not establish its sequence or equivalence to study preparations [1].
Ruff’s inspected abstract concerns intravenous intact thymosin β4 and reports mild or moderate events without serious events. It did not test this blend [2].
Another inspected abstract concerns rodent wound repair with thymosin β4 and synthetic LKKTETQ, rather than clinical adverse reactions [3]. These sources do not support estimating reaction frequencies for the current mixture. Events after exposure are not necessarily caused by it; intact β4 findings cannot establish effects of an unidentified fragment [1–3].
What the studies reported
| Effect | Model or participants | How often or as described | Source |
|---|---|---|---|
| Adverse events of the BPC-157 + TB-500 blend itself | No study of this blend among the cited sources | Reaction frequencies for the blend cannot be estimated: none of the sources tested the mixture | [1–3] |
| Mild or moderate events without serious events (intact thymosin β4, not the blend) | Healthy volunteers, intravenous intact thymosin β4 | Described qualitatively; no serious events; intact β4 findings do not transfer to the blend or an unidentified fragment | [2] |
| Clinical adverse reactions in the wound-repair study | Rodents, thymosin β4 and synthetic LKKTETQ fragment | Clinical adverse reactions were not studied — the study examined wound repair | [3] |
References
- Longeva (2026). BPC-157 + TB-500 Blend https://longeva.bio/ua/product/bpc-157-tb-500.
- Ruff D; Crockford D; Girardi G; Zhang Y (2010). A randomized, placebo-controlled, single and multiple dose study of intravenous thymosin beta4 in healthy volunteers. https://pubmed.ncbi.nlm.nih.gov/20536472/ doi:10.1111/j.1749-6632.2010.05474.x.
- Philp D et al. (2003). Thymosin beta 4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair in db/db diabetic mice and in aged mice. https://pubmed.ncbi.nlm.nih.gov/12581423/ doi:10.1046/j.1524-475x.2003.11105.x.